The IPO Buzz: SpyGlass Pharma Prices IPO at $16 & Stock Jumps 50 Percent on NASDAQ
SpyGlass Pharma (SGP) priced its IPO at $16.00 – the mid-point of its range – and sold about 9.38 million shares – the number in the prospectus – to raise $150 million on Thursday night, Feb. 5, 2026. The medical device company is backed by RA Capital. SpyGlass Pharma’s stock jumped to $24.00 – up $8.00 […]
February 5, 2026 Read More